An Aug 2022 international psoriasis patient survey shows only 14% of Malaysian respondents received the latest biologics treatment, lower than South Korea (37%) and Hong Kong (55%).
Psoriasis is associated with other conditions like diabetes, high cholesterol, ischemic heart disease, fatty liver, and obesity that affect one’s lifespan.